Your browser doesn't support javascript.
loading
An anti-glioblastoma gold(i)-NHC complex distorts mitochondrial morphology and bioenergetics to induce tumor growth inhibition.
Greif, Charles E; Mertens, R Tyler; Berger, Gilles; Parkin, Sean; Awuah, Samuel G.
Afiliação
  • Greif CE; Department of Chemistry, University of Kentucky Lexington Kentucky 40506 USA awuah@uky.edu.
  • Mertens RT; Department of Chemistry, University of Kentucky Lexington Kentucky 40506 USA awuah@uky.edu.
  • Berger G; Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School Boston MA 02115 USA.
  • Parkin S; Microbiology, Bioorganic & Macromolecular Chemistry, Faculté de Pharmacie, Université libre de Bruxelles (ULB), Boulevard du Triomphe 1050 Brussels Belgium.
  • Awuah SG; Department of Chemistry, University of Kentucky Lexington Kentucky 40506 USA awuah@uky.edu.
RSC Chem Biol ; 4(8): 592-599, 2023 Aug 03.
Article em En | MEDLINE | ID: mdl-37547458
ABSTRACT
Glioblastoma multiforme (GBM) is the most lethal brain cancer subtype, often advanced by the time of initial diagnosis. Existing treatment modalities including surgery, chemotherapy and radiation have been stymied by recurrence, metastasis, drug resistance and brain targetability. Here, we report a geometrically distinct Au(i) complex ligated by N^N-bidentate ligands and supported by a N-heterocyclic ligand that modulates mitochondrial morphology to inhibit GBM in vitro and in vivo. This work benefits from the facile preparation of anti-GBM Au(i)-NHC complexes.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Chem Biol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Chem Biol Ano de publicação: 2023 Tipo de documento: Article